Can Moderna Achieve Its Most Ambitious Goal Yet?

Can Moderna Achieve Its Most Ambitious Goal Yet?

Source: 
Motley Fool
snippet: 
  • Investors have worried about Moderna’s post-pandemic earnings since the company relies on its coronavirus vaccine for revenue.
  • Moderna has been progressing toward its goal of becoming a multiproduct company.